<DOC>
	<DOC>NCT02352584</DOC>
	<brief_summary>A Multicenter, Randomized, Double-blind, Active-controlled, Parallel Phase III</brief_summary>
	<brief_title>A Multicenter, Double-blind, Parallel Phase III Study</brief_title>
	<detailed_description>A Multicenter, Randomized, Double-blind, Active-controlled, Parallel Phase III Study to Investigate the Efficacy(Immunogenicity) and Safety of GC3110A(Quadrivalent Influenza Vaccine) After Intramuscular Administration in Healthy Subjects</detailed_description>
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Criteria: Given written informed consent Healthy Korean adults (age: over 19 ) Korean adults who agree with 21 days follow up after vaccination and good compliance to study procedures Those who are able to comply with the requirements for the study Inability in written/verbal communication Subjects who have participated in other interventional study within 30 days Alcohol or drug abuse within 6 months Who got the treatment of psychotropic drugs and narcotic analgesic drugs within 6 months of enrollment Disorders in immune function History of GuillainBarré syndrome Disease/medications which are likely to cause any severe bleeding Active infection or experience of fever (&gt;38.0 ℃) within 72 hours following vaccination Oral temperature &gt;38.0 ℃ at the vaccination day Erythema, tattoo, injury at shoulder (vaccination site) Hypersensitivity with egg, chicken, or any of the vaccine components, or Neomycin, Gentamicin Influenza vaccination within 6months Any vaccination within 30 days Concomitant medications/therapy such as immunosuppressants or immune modifying drugs, systemic corticosteroids, immunoglobulins, blood or blood derived products, or anticancer chemotherapy or radiation therapy within3 months Pregnant or breastfeeding women Clinically significant underlying diseases or medical history at investigator's discretion</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>QIV</keyword>
	<keyword>Quadrivalent Influenza Vaccine</keyword>
	<keyword>Influenza vaccine</keyword>
	<keyword>Vaccination</keyword>
</DOC>